OS THERAPIES INC (OSTX) Forecast, Price Target & Analyst Ratings

NYSEARCA:OSTX • US68764Y2072

Current stock price

1.5 USD
-0.01 (-0.66%)
At close:
1.4 USD
-0.1 (-6.67%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OS THERAPIES INC (OSTX).

Forecast Snapshot

Consensus Price Target

Price Target
$13.01
+ 767.00% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.14
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$13.01
Upside
+ 767.00%
From current price of $1.50 to mean target of $13.01, Based on 10 analyst forecasts
Low
$6.06
Median
$12.75
High
$21.00

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for OSTX. The average price target is 13.01 USD. This implies a price increase of 767% is expected in the next year compared to the current price of 1.5.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

OSTX Current Analyst RatingOSTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

OSTX Historical Analyst RatingsOSTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.00%
OSTX was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about OSTX.
In the previous month the buy percentage consensus was at a similar level.
OSTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-09D. Boral CapitalMaintains Buy -> Buy
2026-02-05D. Boral CapitalMaintains Buy -> Buy
2026-01-05D. Boral CapitalMaintains Buy -> Buy
2025-12-15D. Boral CapitalMaintains Buy -> Buy
2025-12-09D. Boral CapitalMaintains Buy -> Buy
2025-12-05D. Boral CapitalMaintains Buy -> Buy
2025-11-21D. Boral CapitalMaintains Buy -> Buy
2025-11-18Lake StreetMaintains Buy -> Buy
2025-11-17D. Boral CapitalMaintains Buy -> Buy
2025-10-10D. Boral CapitalMaintains Buy -> Buy
2025-09-30D. Boral CapitalMaintains Buy -> Buy
2025-09-12D. Boral CapitalMaintains Buy -> Buy
2025-09-02D. Boral CapitalMaintains Buy -> Buy
2025-08-27D. Boral CapitalMaintains Buy -> Buy
2025-08-20D. Boral CapitalMaintains Buy -> Buy
2025-08-07D. Boral CapitalMaintains Buy -> Buy
2025-07-14D. Boral CapitalMaintains Buy -> Buy
2025-07-03D. Boral CapitalMaintains Buy -> Buy
2025-06-30D. Boral CapitalMaintains Buy -> Buy
2025-06-24D. Boral CapitalMaintains Buy -> Buy
2025-06-10D. Boral CapitalMaintains Buy -> Buy
2025-06-09D. Boral CapitalMaintains Buy -> Buy
2025-05-15D. Boral CapitalMaintains Buy -> Buy
2025-04-22D. Boral CapitalMaintains Buy -> Buy
2025-04-07D. Boral CapitalMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.14
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
42.20%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
2.86%

Next Earnings Summary

OSTX is expected to report earnings on 4/6/2026. The consensus EPS estimate for the next earnings is -0.14 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
OSTX revenue by date.OSTX revenue by date.
N/AN/AN/A
113.94%		N/A
140.90%		N/A
28.51%		N/A
170.32%		N/A
213.68%		N/A
28.97%		N/A
6.49%
EBITDA
YoY % growth
OSTX ebitda by date.OSTX ebitda by date.
-4.837M-4.446M
8.09%		-4.339M
2.41%		-6.811M
-56.99%		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
OSTX ebit by date.OSTX ebit by date.
-4.837M-4.446M
8.08%		-4.343M
2.33%		-6.814M
-56.90%		N/A
-217.37%		N/A
28.36%		N/A
62.94%		N/A
217.49%		N/A
60.39%		N/A
690.91%		N/A
445.79%		N/A
31.02%		N/A
6.61%
Operating Margin
OSTX operating margin by date.OSTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
OSTX eps by date.OSTX eps by date.
N/AN/AN/AN/AN/A
35.31%		N/A
37.39%		N/A
62.38%		N/A
38.46%		N/A
13.30%		N/A
2,279.93%		N/A
785.71%		N/A
18.64%		N/A
-5.09%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.14
42.20%		-0.17
27.75%		-0.18
6.05%		-0.17
19.86%		-0.11
22.79%
Revenue
Q2Q % growth		3.06M14.28M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-4.577M
-54.31%		-5.521M
-10.44%		-5.662M
-17.00%		-5.484M
20.29%		-3.941M
13.91%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

OSTX Yearly Revenue VS EstimatesOSTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
OSTX Yearly EPS VS EstimatesOSTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.71%
EPS Next 5 Year
13.92%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
445.88%
Revenue Next 5 Year
247.07%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

OS THERAPIES INC / OSTX Forecast FAQ

What do analysts expect the price target to be for OS THERAPIES INC (OSTX)?

10 analysts have analysed OSTX and the average price target is 13.01 USD. This implies a price increase of 767% is expected in the next year compared to the current price of 1.5.

Can you provide the upcoming earnings date for OS THERAPIES INC?

OS THERAPIES INC (OSTX) will report earnings on 2026-04-06.

What are the consensus estimates for OS THERAPIES INC (OSTX) next earnings?

The consensus EPS estimate for the next earnings of OS THERAPIES INC (OSTX) is -0.14 USD and the consensus revenue estimate is 0 USD.

What is the expected long term growth rate for OSTX stock?

The expected long term growth rate for OS THERAPIES INC (OSTX) is 445.88%.